• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旨在了解三磷酸卡波韦对野生型和突变型HIV-1逆转录酶抑制作用的机制研究。

Mechanistic studies to understand the inhibition of wild type and mutant HIV-1 reverse transcriptase by Carbovir-triphosphate.

作者信息

Ray A S, Anderson K S

机构信息

Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06520-8066, USA.

出版信息

Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):1247-50. doi: 10.1081/NCN-100002528.

DOI:10.1081/NCN-100002528
PMID:11562995
Abstract

Abacavir (1592U89) has recently been approved by the FDA for treatment of HIV infection. Transient kinetic studies were carried out to better understand the interaction of the active metabolite of Abacavir (Carbovir-triphosphate) with wild type and mutant HIV-1 reverse transcriptase. Some of the data is summarized and used as a basis for discussion of inhibition by CBVTP and previously studied nucleoside analogs.

摘要

阿巴卡韦(1592U89)最近已获美国食品药品监督管理局(FDA)批准用于治疗HIV感染。进行了瞬态动力学研究,以更好地了解阿巴卡韦的活性代谢物(卡波韦三磷酸)与野生型和突变型HIV-1逆转录酶之间的相互作用。部分数据进行了总结,并用作讨论CBVTP和先前研究的核苷类似物抑制作用的基础。

相似文献

1
Mechanistic studies to understand the inhibition of wild type and mutant HIV-1 reverse transcriptase by Carbovir-triphosphate.旨在了解三磷酸卡波韦对野生型和突变型HIV-1逆转录酶抑制作用的机制研究。
Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):1247-50. doi: 10.1081/NCN-100002528.
2
The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.空间位阻在1型人类免疫缺陷病毒逆转录酶3TC耐药性中的作用。
J Mol Biol. 2000 Jul 7;300(2):403-18. doi: 10.1006/jmbi.2000.3823.
3
Insights into the molecular mechanism of inhibition and drug resistance for HIV-1 RT with carbovir triphosphate.对三磷酸卡波韦抑制HIV-1逆转录酶及耐药性分子机制的见解。
Biochemistry. 2002 Apr 23;41(16):5150-62. doi: 10.1021/bi0121858.
4
Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.野生型和对3'-叠氮-3'-脱氧胸苷(AZT)耐药的1型人类免疫缺陷病毒逆转录酶的稳态前动力学特征:RNA指导的DNA聚合反应在AZT耐药机制中的意义
Biochemistry. 1997 Nov 18;36(46):14064-70. doi: 10.1021/bi9713862.
5
Understanding the basis of resistance in the irksome Lys103Asn HIV-1 reverse transcriptase mutant through targeted molecular dynamics simulations.通过靶向分子动力学模拟理解令人讨厌的Lys103Asn HIV-1逆转录酶突变体的耐药性基础。
J Am Chem Soc. 2004 Dec 1;126(47):15386-7. doi: 10.1021/ja045409t.
6
Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.猫免疫缺陷病毒/1型人类免疫缺陷病毒逆转录酶嵌合体对非核苷类逆转录酶抑制剂的敏感性。
Mol Pharmacol. 2004 Jan;65(1):244-51. doi: 10.1124/mol.65.1.244.
7
Outsmarting HIV drug resistance.智胜HIV耐药性。
Science. 1998 Nov 27;282(5394):1623, 1625.
8
Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors.对1型人类免疫缺陷病毒逆转录酶(RT)的trp-229进行突变分析,确定该氨基酸残基是新型非核苷逆转录酶抑制剂合理设计的主要靶点。
Mol Pharmacol. 2000 May;57(5):954-60.
9
Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.对人类免疫缺陷病毒1型逆转录酶第138位氨基酸进行定点诱变。
Virology. 2001 Feb 1;280(1):97-106. doi: 10.1006/viro.2000.0742.
10
Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase.弯曲假结与1型人类免疫缺陷病毒(HIV-1)逆转录酶的新型RNA抑制剂。
J Mol Biol. 1996 Dec 13;264(4):650-66. doi: 10.1006/jmbi.1996.0667.

引用本文的文献

1
Selection and characterization of Autographa californica multiple nucleopolyhedrovirus DNA polymerase mutations.美洲棉铃虫多角体病毒 DNA 聚合酶突变的选择与鉴定。
J Virol. 2012 Dec;86(24):13576-88. doi: 10.1128/JVI.01507-12. Epub 2012 Oct 3.
2
Mechanism of anti-human immunodeficiency virus activity of beta-D-6-cyclopropylamino-2',3'-didehydro-2',3'-dideoxyguanosine.β-D-6-环丙氨基-2',3'-二脱氢-2',3'-二脱氧鸟苷抗人免疫缺陷病毒活性的机制
Antimicrob Agents Chemother. 2005 May;49(5):1994-2001. doi: 10.1128/AAC.49.5.1994-2001.2005.
3
Diminished RNA primer usage associated with the L74V and M184V mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity.
与1型人类免疫缺陷病毒逆转录酶中的L74V和M184V突变相关的RNA引物使用减少,为病毒复制能力降低提供了一种可能的机制。
J Virol. 2003 Aug;77(16):8621-32. doi: 10.1128/jvi.77.16.8621-8632.2003.
4
Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agent.采用鸟苷前药方法将2',3'-二脱氢-2',3'-二脱氧鸟苷转化为一种可行的抗病毒药物的新用途。
Antimicrob Agents Chemother. 2002 Mar;46(3):887-91. doi: 10.1128/AAC.46.3.887-891.2002.